Table 1 Characteristics of Cases and Controls
From: Pilot case-control investigation of risk factors for hip fractures in the urban Indian population
Variable | Case | Controls |
|---|---|---|
Note: Plus - minus values are Means ± Standard Deviations | (n = 100) | (n = 100) |
Sex Distribution: | Â | Â |
Male | 43 | 43 |
Female | 57 | 57 |
Mean Age | 65.7 ± 16.1 | 64.7 ± 13.8 |
Male | 69.9 ± 9.2 | 66 ± 4.2 |
Female | 60.1 ± 20 | 63.1 ± 15.1 |
Mean Weight | 64 ± 10.4 | 67 ± 11.2 |
Male | 65.5 ± 12.5 | 68.6 ± 11.1 |
Female | 62.8 ± 8.3 | 63.5 ± 10.3 |
Mean Height | 64.6 ± 4.7 | 65.9 ± 3.0 |
Male | 67.0 ± 5.8 | 67.4 ± 3.0 |
Female | 62.9 ± 8.7 | 62.8 ± 2.8 |
Mean Body Mass Index (BMI) | 22.8 ± 3.8 | 23.8 ± 3.4 |
Male | 22.5 ± 3.1 | 23.3 ± 3.5 |
Female | 24.8 ± 3.9 | 25.1 ± 5.1 |
% Taking Medication for: | Â | Â |
a) None | 47 | 67 |
b) Hypertension (β-Blockers, Ace Inhibitors, Calcium Channel Blockers, Thiazide Diuretics) | 27 | 15 |
c) Diabetes (Insulin, Sulfonylurea e.g. Glyburide, Biguanides eg. Metformin) | 8 | 7 |
d) Asthma (β2 Agonists e.g. Epinephrine, Albuterol inhalers) | 4 | 1 |
e) Cardiac | 0 | 0 |
f) Homeopathy/Ayurveda | 1 | 2 |
g) Cardiac & Hypertension on (Drugs listed in b, plus Aspirin, Nitroglycerin) | 6 | 6 |
h) Diabetes & Hypertension (b and c) | 3 | 2 |
i) Thyroid Hormone | 4 | 0 |
Mean Pulse Rate: | 75.9 ± 6.3 | 75.9 ± 6.3 |
Male | 75.4 ± 6.4 | 75.4 ± 6.4 |
Female | 76.4 ± 6.3 | 76.4 ± 6.3 |